These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 11032429)

  • 1. Schizophrenia and plasma homovanillic acid in response to mental stress: methodological considerations.
    Sumiyoshi T; Kurachi M; Itoh H
    Neuropsychopharmacology; 2000 Sep; 23(3):347-9. PubMed ID: 11032429
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on plasma levels of homovanillic acid (phVA) under influence of mental stress.
    Oranje B; Bijl S; Campagne A; Gispen-de Wied CC
    Neuropsychopharmacology; 2000 Sep; 23(3):345-6. PubMed ID: 11032428
    [No Abstract]   [Full Text] [Related]  

  • 3. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls.
    Duncan E; Bollini AM; Sanfilipo M; Wieland S; Angrist B; Cooper TB; Rotrosen J
    Schizophr Res; 2006 Jan; 81(2-3):323-6. PubMed ID: 16181774
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of mental stress on plasma homovanillic acid in schizophrenia and normal controls.
    Sumiyoshi T; Saitoh O; Yotsutsuji T; Itoh H; Kurokawa K; Kurachi M
    Neuropsychopharmacology; 1999 Apr; 20(4):365-9. PubMed ID: 10088137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients.
    Doran AR; Pickar D; Labarca R; Douillet P; Wolkowitz OM; Thomas JW; Roy A; Paul SM
    Psychopharmacol Bull; 1985; 21(3):694-7. PubMed ID: 4034886
    [No Abstract]   [Full Text] [Related]  

  • 6. Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophrenia.
    Doran AR; Labarca R; Wolkowitz OM; Roy A; Douillet P; Pickar D
    Arch Gen Psychiatry; 1990 Jun; 47(6):558-63. PubMed ID: 2350208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morning variations of plasma homovanillic acid in untreated schizophrenic patients.
    Zumárraga M; Andía I; Bárcena B; González-Torres MA; Dávila R
    J Psychiatr Res; 1993; 27(1):11-6. PubMed ID: 8515382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls.
    Davidson M; Davis KL
    Arch Gen Psychiatry; 1988 Jun; 45(6):561-3. PubMed ID: 3377642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of mental stress on plasma homovanillic acid in healthy human subjects.
    Sumiyoshi T; Yotsutsuji T; Kurachi M; Itoh H; Kurokawa K; Saitoh O
    Neuropsychopharmacology; 1998 Jul; 19(1):70-3. PubMed ID: 9608578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of plasma homovanillic acid concentrations in schizophrenic patients.
    Kaminski R; Powchick P; Warne PA; Goldstein M; McQueeney RT; Davidson M
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):271-87. PubMed ID: 2193315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia: gender, family risk, and plasma homovanillic acid.
    Dávila R; Zumárraga M; González-Torres MA; Andía I; Zamalloa MI; Basterreche E; Guimón J; Friedhoff AJ
    Am J Med Genet; 1995 Apr; 60(2):154-6. PubMed ID: 7485251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma homovanillic acid as a predictor of response to fluphenazine treatment.
    Van Putten T; Marder SR; Aravagiri M; Chabert N; Mintz J
    Psychopharmacol Bull; 1989; 25(1):89-91. PubMed ID: 2772121
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of debrisoquin on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M; Losonczy MF; Mohs RC; Powchick P; Freed LB; Kaminsky R; Davis KL
    Psychopharmacol Bull; 1987; 23(3):407-10. PubMed ID: 3432512
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma homovanillic acid level inpatients with deficit forms of schizophrenics].
    Ribeyre JM; Lesieur P; Varoquaux O; Dollfus S; Gregoire A; Ménard JF; Petit M
    Presse Med; 1991 Nov; 20(39):1947. PubMed ID: 1837093
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma homovanillic acid concentration and the severity of schizophrenic illness.
    Davis KL; Davidson M; Mohs RC; Kendler KS; Davis BM; Johns CA; DeNigris Y; Horvath TB
    Science; 1985 Mar; 227(4694):1601-2. PubMed ID: 3975630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal variation in plasma homovanillic acid: not a renal phenomenon.
    Stroe AE; Amin F; Hashmi A; Densmore D; Kahn T; Knott PJ
    Biol Psychiatry; 1997 Mar; 41(5):621-3. PubMed ID: 9046995
    [No Abstract]   [Full Text] [Related]  

  • 18. Vulnerability to stress: self-criticism and stress-induced changes in biochemistry.
    Gruen RJ; Silva R; Ehrlich J; Schweitzer JW; Friedhoff AJ
    J Pers; 1997 Mar; 65(1):33-47. PubMed ID: 9143144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of plasma homovanillic acid in schizophrenic patients.
    Davidson M; Kahn RS; Stern RG; Harvey PD; Keefe R; Knott P; Apter S; Webster L; Davis KL
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():521A-522A. PubMed ID: 1354058
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma homovanillic acid, serum anti-D1 and anti-D2 receptor activity, and psychopathology in chronic schizophrenia.
    Koshikawa H; Suzuki E; Kanba S; Nibuya M; Ishizuki T; Kohno H; Kinoshita N; Shintani F; Yagi G; Nakaki T
    Yakubutsu Seishin Kodo; 1991 Feb; 11(1):79-81. PubMed ID: 1679276
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.